Fig. 3.

Change in height velocity at 6 months. Data are mean (SD); only positive SD are shown. p values are for within- group comparisons. Intention-to-treat with LOCF. Treatment group: n = 59 (1 patient was excluded from the baseline and change from baseline analyses owing to no height value recorded for 6 months prior to screening; this patient withdrew and there were no data after visit 1). Control group: n = 29 (6-month height measurements were missing for 3 children; these were replaced by measurements at withdrawal for 2 children; 1 child had no post-baseline measurement and, therefore, was not included in the analysis). LOCF, last observation carried forward; r-hGH, recombinant human growth hormone; SD, standard deviation.